НовостиBenzingaPiper Sandler Reiterates Overweight on Beta Bionics, Raises Price Target to $24 Piper Sandler Reiterates Overweight on Beta Bionics, Raises Price Target to $24 Benzinga 2026.10.28 15:51 (GMT+0) Открыть на Benzinga Другие новости